A Co-Author Declines

I enjoyed very much reading the article "Opting Out of the Numbers Game" . I hope that some attention is paid to the sentiments expressed. I spent better than 20 years in academia. I do not mean to pat myself on the back, but I have declined to be co-author on more papers than I have been a co-author. Sometimes I felt I was added as a co-author because I walked through the lab and I was better known internationally than were the primary authors. A number of bitter arguments resulted when I decli

Written byBruce Burnham
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I spent better than 20 years in academia. I do not mean to pat myself on the back, but I have declined to be co-author on more papers than I have been a co-author. Sometimes I felt I was added as a co-author because I walked through the lab and I was better known internationally than were the primary authors. A number of bitter arguments resulted when I declined to be included. Perhaps it is typical that I am co-author of two or three papers that I never even saw. It is embarrassing to be confronted at a meeting by someone asking for details of a paper that was published without my knowledge.

I sincerely hope it will be possible for academia to opt out of the numbers game.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies